{"transactions":[{"id":3313075,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":152432,"kind":"organization","name":"AEON Biopharma, Inc.","position":1,"cik":"0001622667","reported_name":"AEON Biopharma, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-01-10T21:10:45.000Z","date":"2020-01-08","kind":"other","acquired":false,"shares":8662346,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a Contribution Agreement dated January 8, 2020, by and between the Reporting Person (formerly known as Alphaeon Corporation) and Alphaeon 1 LLC (\"Alphaeon\"), on January 8, 2020, the Reporting Person contributed 8,662,346 shares of the Issuer to Alphaeon (the \"Contribution\").  The shares of the Issuer contributed to Alphaeon are deemed \"restricted securities\" under Rule 144 promulgated under the Securities Act of 1933, as amended.  At the time of the Contribution, Alphaeon was a wholly-owned subsidiary of the Reporting Person.  Immediately after the Contribution, the Reporting Person distributed out all of the membership interests of Alphaeon to its stockholders.  The Reporting Person is filing this exit Form 4 to report that it is no longer a beneficial owner of the Issuer's securities."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001078782-20-000010","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000107878220000010/primary_doc.xml","form_type":"4"}},{"id":3501731,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":152432,"kind":"organization","name":"AEON Biopharma, Inc.","position":1,"cik":"0001622667","reported_name":"Alphaeon Corp","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-06-04T23:40:29.000Z","date":"2019-06-03","kind":"sale","acquired":false,"shares":1298701,"price":19.25,"value":24999994.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The acquisition of the shares of common stock referenced in this Form 4 was conducted in a private transaction between ALPHAEON Corporation (\"ALPHAEON\")  and Strathspey Crown Holdings Group, LLC (\"SCH\"). SCH is a majority shareholder of ALPHAEON. The shares of common stock received by SCH are deemed \"restricted securities\" under Rule 144 promulgated under the Securities Act of 1933, as amended."},{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of the shares of common stock referenced in this Form 4 was conducted in a private transaction between ALPHAEON Corporation (\"ALPHAEON\")  and Strathspey Crown Holdings Group, LLC (\"SCH\"). SCH is a majority shareholder of ALPHAEON. The shares of common stock received by SCH are deemed \"restricted securities\" under Rule 144 promulgated under the Securities Act of 1933, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The acquisition of the shares of common stock referenced in this Form 4 was conducted in a private transaction between ALPHAEON Corporation (\"ALPHAEON\")  and Strathspey Crown Holdings Group, LLC (\"SCH\"). SCH is a majority shareholder of ALPHAEON. The shares of common stock received by SCH are deemed \"restricted securities\" under Rule 144 promulgated under the Securities Act of 1933, as amended."}],"balance_after":8662346,"source":{"system":"sec-edgar","filing":"0001078782-19-000500","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000107878219000500/primary_doc.xml","form_type":"4/A","original_submission_date":"2019-06-04"}},{"id":3501728,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":152432,"kind":"organization","name":"AEON Biopharma, Inc.","position":1,"cik":"0001622667","reported_name":"Alphaeon Corp","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-06-04T23:03:52.000Z","date":"2019-06-03","kind":"sale","acquired":false,"shares":1298701,"price":19.25,"value":24999994.25,"ownership":{"direct":true},"balance_after":8662346,"source":{"system":"sec-edgar","filing":"0001078782-19-000499","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000107878219000499/primary_doc.xml","form_type":"4"}},{"id":3514683,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":152432,"kind":"organization","name":"AEON Biopharma, Inc.","position":1,"cik":"0001622667","reported_name":"Alphaeon Corp","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-05-22T23:04:46.000Z","date":"2019-05-22","kind":"sale","acquired":false,"shares":290518,"price":19.25,"value":5592471.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition of an aggregate of 1,307,940 shares of common stock was made pursuant to a private transaction with certain of Alphaeon Corporation's existing noteholders who elected to receive payment of certain outstanding amounts under their notes due June 23, 2019 in the form of shares of common stock rather than cash. The shares of common stock received by the noteholders are deemed \"restricted securities\" under Rule 144 promulgated under the Securities Act of 1933, as amended."}],"balance_after":9961047,"source":{"system":"sec-edgar","filing":"0001078782-19-000477","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000107878219000477/primary_doc.xml","form_type":"4"}},{"id":3514682,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":152432,"kind":"organization","name":"AEON Biopharma, Inc.","position":1,"cik":"0001622667","reported_name":"Alphaeon Corp","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-05-22T23:04:46.000Z","date":"2019-05-20","kind":"sale","acquired":false,"shares":1017422,"price":19.25,"value":19585373.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition of an aggregate of 1,307,940 shares of common stock was made pursuant to a private transaction with certain of Alphaeon Corporation's existing noteholders who elected to receive payment of certain outstanding amounts under their notes due June 23, 2019 in the form of shares of common stock rather than cash. The shares of common stock received by the noteholders are deemed \"restricted securities\" under Rule 144 promulgated under the Securities Act of 1933, as amended."}],"balance_after":10251565,"source":{"system":"sec-edgar","filing":"0001078782-19-000477","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000107878219000477/primary_doc.xml","form_type":"4"}},{"id":3514681,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":152432,"kind":"organization","name":"AEON Biopharma, Inc.","position":1,"cik":"0001622667","reported_name":"Alphaeon Corp","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-05-22T23:04:46.000Z","date":"2019-05-20","kind":"sale","acquired":false,"shares":4000000,"price":19.25,"value":77000000.0,"ownership":{"direct":true},"balance_after":11268987,"source":{"system":"sec-edgar","filing":"0001078782-19-000477","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000107878219000477/primary_doc.xml","form_type":"4"}},{"id":3745647,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":152432,"kind":"organization","name":"AEON Biopharma, Inc.","position":1,"cik":"0001622667","reported_name":"Alphaeon Corp","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-12-03T21:07:42.000Z","date":"2018-11-29","kind":"sale","acquired":false,"shares":573888,"price":14,"value":8034432.0,"ownership":{"direct":true},"balance_after":15268987,"source":{"system":"sec-edgar","filing":"0001078782-18-001389","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000107878218001389/primary_doc.xml","form_type":"4"}},{"id":3816741,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":152432,"kind":"organization","name":"AEON Biopharma, Inc.","position":1,"cik":"0001622667","reported_name":"Alphaeon Corp","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-09-13T16:31:30.000Z","date":"2018-09-11","kind":"sale","acquired":false,"shares":1750000,"price":21.04,"value":36820000.0,"ownership":{"direct":true},"balance_after":15842875,"source":{"system":"sec-edgar","filing":"0001078782-18-000975","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000107878218000975/primary_doc.xml","form_type":"4"}},{"id":3862570,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":152432,"kind":"organization","name":"AEON Biopharma, Inc.","position":1,"cik":"0001622667","reported_name":"Alphaeon Corp","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-07-23T20:01:41.000Z","date":"2018-07-23","kind":"sale","acquired":false,"shares":1000000,"price":18.8,"value":18800000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Persons sold shares to the underwriters in connection with the closing of the Issuer's follow-on public offering. The reported sale price reflects the price at which the Reporting Persons sold shares to the underwriters, which is net of underwriting commissions."}],"balance_after":17592875,"source":{"system":"sec-edgar","filing":"0001570562-18-000094","document":"wf-form4_153237608581846.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000157056218000094/wf-form4_153237608581846.xml","form_type":"4"}},{"id":4062086,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":152432,"kind":"organization","name":"AEON Biopharma, Inc.","position":1,"cik":"0001622667","reported_name":"Alphaeon Corp","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2018-02-14T01:08:34.000Z","date":"2018-02-12","kind":"exercise","acquired":false,"shares":1250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Effective immediately upon the closing of the Issuer's initial public offering of its common stock under the Securities Act of 1933, as amended, each share of Series A preferred stock automatically converted into 1.6527 shares of the Issuer's common stock. The Series A preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Effective immediately upon the closing of the Issuer's initial public offering of its common stock under the Securities Act of 1933, as amended, each share of Series A preferred stock automatically converted into 1.6527 shares of the Issuer's common stock. The Series A preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Effective immediately upon the closing of the Issuer's initial public offering of its common stock under the Securities Act of 1933, as amended, each share of Series A preferred stock automatically converted into 1.6527 shares of the Issuer's common stock. The Series A preferred stock had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Reflects a 1.6527-for-1 forward stock split of the Issuer's common stock effected on January 26, 2018."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2065875},"source":{"system":"sec-edgar","filing":"0001628280-18-001613","document":"wf-form4_151857049936322.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000162828018001613/wf-form4_151857049936322.xml","form_type":"4"}},{"id":4062085,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":152432,"kind":"organization","name":"AEON Biopharma, Inc.","position":1,"cik":"0001622667","reported_name":"Alphaeon Corp","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-02-14T01:08:34.000Z","date":"2018-02-12","kind":"exercise","acquired":true,"shares":2065875,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a 1.6527-for-1 forward stock split of the Issuer's common stock effected on January 26, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Effective immediately upon the closing of the Issuer's initial public offering of its common stock under the Securities Act of 1933, as amended, each share of Series A preferred stock automatically converted into 1.6527 shares of the Issuer's common stock. The Series A preferred stock had no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects a 1.6527-for-1 forward stock split of the Issuer's common stock effected on January 26, 2018."}],"balance_after":2065875,"source":{"system":"sec-edgar","filing":"0001628280-18-001613","document":"wf-form4_151857049936322.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000162828018001613/wf-form4_151857049936322.xml","form_type":"4"}}]}